Becton, Dickinson and Co. | BDX - Ebit

Aktienkurs
154.12
Täglich Wechseln
-2.41 -1.54%
Monatlich
-16.39%
Jährlich
-33.06%
Q1 Prognose
154.55




Ebit Veränderung Datum
Abbott USD 2.54B 358M 2025-12
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
AngioDynamics USD -2.51M 5.41M 2025-09
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio-Rad Laboratories USD -418.8M 845.4M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Globus Medical USD 181.31M 298.83M 2025-12
Hologic USD 240.9M 12.1M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 5.11B 2.3B 2025-12
Masimo USD 83.9M 200K 2025-12
Medtronic USD 1.74B 40M 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12